Cite
HARVARD Citation
Talamonti, M. et al. (n.d.). Pharmacogenetics of psoriasis: HLA‐Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab. British journal of dermatology. pp. 458-463. [Online].